TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
DON'T BUY
Broadly speaking, the financial area is extended and this is one that is more extended. It would be nice if they came up with another great idea, which would move it a bit.
BUY
Has some good growth prospects. Have made some astute acquisitions. Good dividend and solid earnings. 2% dividend.
BUY
Has had a good pop because of the move of money out of income trusts. Growing rapidly in Asia.
BUY
A good, solid company. Have done some great acquisitions. Not a bargain at these prices, but if you are looking for a solid financial company, well-run, global outlook this would be a good one.
HOLD
Selling pretty close to its all time high price. Extremely well managed. Continue to surprise with their earnings growth. Good investment over the long term.
BUY
Good growth rate. To have an insurance company along with a bank is good diversification and helps offset any commodity risk in your portfolio.
BUY
One of his favourite Canadian companies. A real international player.
TOP PICK
Spectacular company. Great management. Likes their Asian exposure. Recent numbers show 20% ROE and 16 X earnings. Increasing their share buyback.
BUY
His favourite life insurance Company and North America. The best run company. As great growth potential in the US. Thinks they are poised to make another major acquisition. The real kicker is they're far east operations. Lots of upside.
BUY
Getting long-term growth from their John Hancock holdings in the US as well as Asia. Excellent management. 1.3% yield.
HOLD
A solid, blue-chip and blue chips are in favour now. The best Canadian group in terms of acquisition and probably lined up to do another. Good operations in Asia.
BUY ON WEAKNESS
Seasonal pattern for the financial sector is from the end of September to the end of May. Technically, the stock is getting into gear. Right now, the stock is a little bit overbought.
BUY
Banks have had a big move, so you could play the life insurance companies at this time.
TOP PICK
About 20-25% Canadian, 55-60% US and the rest in the far east. 70% of this business is wealth management. They are good with acquisitions. Good price for a 3-5-year hold.
BUY
The best run life insurance company in North America. They have the best management and the best balance sheet. Likes their growth prospects in the far east.
Showing 1,846 to 1,860 of 2,283 entries